Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
Unusual Results01:16

Unusual Results

Unusual results are those that have a very low chance of occurring. Unusual results can be identified using probabilities and the range rule of thumb. In problems involving probability, unusual results can be observed in 2 instances – an unusually high number of successes or an unusually low number of successes.
According to the range rule of thumb, any value above or below two standard deviations, 2σ  from the mean, μ  is considered unusual.
Maximum unusual value = μ + 2σ
Minimum unusual value...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Critical Region, Critical Values and Significance Level01:16

Critical Region, Critical Values and Significance Level

The critical region, critical value, and significance level are interdependent concepts crucial in hypothesis testing.
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in  probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the test...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of end-stage renal disease mediated by cuproptosis-related genes.

Clinical nephrology·2026
Same author

Premature Aortic Stiffness in Relation to Cerebral Small Vessel Disease, Cognitive Decline, Major Cardiovascular Events and Mortality in Dialysis.

American journal of nephrology·2026
Same author

Erratum: "Thermal and chemical control of emission and excited-state dynamics in non-(TMS)3P-derived InP quantum dots" [J. Chem. Phys. 164, 144702 (2026)].

The Journal of chemical physics·2026
Same author

Comparative efficacy of CDK4/6 inhibitors palbociclib, ribociclib, and abemaciclib in HR<sup>+</sup>/HER2<sup>-</sup> advanced breast cancer.

American journal of cancer research·2026
Same author

Undulating Cylinder-in-Lamellae Morphologies Formed in Giant Bolaform Lipids.

Polymer science & technology (Washington, D.C.)·2026
Same author

Stoichiometry-Induced Band Gap Opening in Epitaxial Degenerate Copper Sulfide Thin Films.

The journal of physical chemistry letters·2026
Same journal

Protein dynamic simulations: From early inception to clinical translation over half a century.

Computational biology and chemistry·2026
Same journal

Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer.

Computational biology and chemistry·2026
Same journal

In silico characterization of acetyl-CoA carboxylase from Staphylococcus aureus and Escherichia coli: A comparative analysis.

Computational biology and chemistry·2026
Same journal

An optimized cascaded transformer with progressive attention for lung and colon cancer diagnosis from histopathological images.

Computational biology and chemistry·2026
Same journal

From cross cancer transcriptomics to therapeutics: WGX-50 target hub genes in breast cancer and non-small cell lung carcinoma.

Computational biology and chemistry·2026
Same journal

Blood-based biomarker discovery through integrative transcriptomic and miRNA network analyses in schizophrenia, major depressive disorder, and bipolar disorder.

Computational biology and chemistry·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Rare variants analysis by risk-based variable-threshold method.

Hongyan Fang1, Bo Hou, Qi Wang

  • 1Department of Statistics and Finance, University of Science and Technology of China, Hefei, Anhui 230026, China.

Computational Biology and Chemistry
|June 15, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method for identifying disease-associated rare variants by pooling them based on risk measures. This approach improves the power of association testing and variant selection in genetic studies.

Keywords:
Genome-wide association studyPooled association testsRare variantsVariable-threshold approach

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: May 10, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

  • Genetics
  • Bioinformatics
  • Statistical genomics

Background:

  • Genome-wide association studies (GWAS) effectively identify common variants linked to diseases.
  • Traditional GWAS methods lack power to detect rare variants due to limited sample sizes.
  • Pooling functional rare variants into composite markers offers a strategy to enhance detection.

Purpose of the Study:

  • To propose a new pooling method for testing variant-disease associations.
  • To identify functional rare variants contributing to disease susceptibility.
  • To improve the power of detecting associations involving rare genetic variants.

Main Methods:

  • A novel pooling strategy is introduced, grouping rare variants based on risk measures (allele frequency ratios between cases and controls).
  • A chi-square test is applied to the pooled data, with the maximal chi-square statistic used across all possible pooling thresholds.
  • The method thresholds on risk measures, differentiating it from existing variable-threshold approaches that use control allele frequencies.

Main Results:

  • The proposed pooling method demonstrates superior performance in association testing compared to traditional methods.
  • The approach shows enhanced capability in selecting functional rare variants related to diseases.
  • Simulation results confirm the method's effectiveness in both association detection and variant identification.

Conclusions:

  • The developed pooling method offers a powerful alternative for analyzing rare variants in genetic association studies.
  • This approach enhances the ability to identify disease-susceptible genes by effectively pooling functional rare variants.
  • The method provides a statistically robust framework for rare variant association analysis, improving upon existing techniques.